Badger Meter, Inc.(BMI)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
BMI | 3.74 B | 30.14x | -6.60% | 14.27% | $4.28 | 18.48% | 0.03x | 1.26% | $204.00 | $112.09 |
CGNX | 9.55 B | 54.59x | 16.90% | 16.05% | $1.04 | 11.15% | 0.04x | 0.62% | $72.78 | $34.45 |
RAL | 7.41 B | - | 12.80% | -56.39% | -$10.93 | -53.90% | 0.80x | 0.30% | $75.35 | $37.17 |
NOVT | 5.13 B | 85.82x | 10.30% | 6.00% | $1.58 | 5.11% | 0.18x | 0.00% | $176.38 | $98.27 |
VNT | 4.60 B | 14.05x | -2.20% | 11.34% | $2.42 | 28.90% | 1.61x | 0.30% | $48.09 | $27.21 |
Peer Valuation & Performance Analysis
Peer group analysis for Badger Meter, Inc. (BMI) compared to its primary competitors (including CGNX, RAL, NOVT) reveals distinct metrics. BMI trades at a valuation discount relative to its competitors, with a P/E ratio of 30.1x versus the peer average of 37.1x (representing a 19% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, BMI's revenue growth of -6.6% lags behind the peer average of 9.4%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 14.3% compared to the peer average of -5.7%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• BMI ranks #2 in P/E ratio, #5 in revenue growth, and #2 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $126.20 | $129.43 | $125.05 | $129.01 | 378,822 | +2.18% |
| 2026-10-19 | $127.07 | $128.30 | $125.73 | $126.26 | 313,700 | -0.17% |
| 2026-10-16 | $127.04 | $129.24 | $125.87 | $126.48 | 308,100 | -0.32% |
| 2026-10-15 | $127.81 | $130.05 | $124.08 | $126.88 | 426,800 | -1.23% |
| 2026-10-14 | $130.37 | $131.86 | $127.90 | $128.46 | 296,600 | -2.13% |
| 2026-10-13 | $130.40 | $132.32 | $128.63 | $131.25 | 316,000 | -0.86% |
| 2026-10-12 | $130.74 | $133.31 | $128.47 | $132.39 | 265,200 | +0.77% |
| 2026-10-09 | $128.60 | $133.80 | $126.82 | $131.38 | 522,600 | +2.91% |
| 2026-10-08 | $123.85 | $128.01 | $123.57 | $127.66 | 408,100 | +2.89% |
| 2026-10-07 | $122.51 | $125.39 | $122.00 | $124.07 | 417,100 | +0.27% |
| 2026-10-06 | $125.22 | $126.96 | $122.64 | $123.73 | 344,800 | -0.93% |
| 2026-10-05 | $127.22 | $127.22 | $124.01 | $124.89 | 456,900 | -2.25% |
| 2026-10-02 | $130.30 | $131.12 | $127.10 | $127.77 | 602,000 | -0.47% |
| 2026-10-01 | $124.26 | $128.89 | $122.52 | $128.37 | 385,200 | +3.91% |
| 2026-09-30 | $126.41 | $126.41 | $123.54 | $123.54 | 335,700 | -1.94% |
Explore More Analysis for BMI
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.